Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11027031 | ILLUCCIXgallium ga-68 gozetotide | use | Jul 2035 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ILLUCCIX | Kit for the preparation of gallium Ga 68 gozetotide injection | kit, intravenous | 74725-100NDA |
Enquiry
Common questions
- Is Telix Pharmaceuticals (US) Inc. FDA approved?
- Telix Pharmaceuticals (US) Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Telix Pharmaceuticals (US) Inc. make?
- 1 product is listed under Telix Pharmaceuticals (US) Inc. in the openFDA NDC Directory, most often as kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.